Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) Stock Forecast: StockMap's 2-Week Call
HLN stock forecast: StockMap's model leans Underperform on Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for the two weeks after the Nov 19 close, toward HLN trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Too few two-week windows graded to judge yet.
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) last closed at $9.05, -0.33% on the session.
Against the IVW growth benchmark the position is +2.00% over the forecast window.
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)'s market cap is $39.68B as of November 19, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -27 (too close to call).
Where HLN sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 5 bullish and 10 bearish.
Agreement across those insights is 67%.
13 daily calls for HLN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is classified under Health Care / Pharmaceuticals.
StockMap tracks Haleon plc American Depositary Shares (Each representing two Ordinary Shares) as the 13th largest of the 153 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.
Across that group the current two-week reads are 80 Moderate Underperform, 44 Neutral and 29 Strong Underperform.
On that composite Haleon plc American Depositary Shares (Each representing two Ordinary Shares) ranks 59th of 153 in the group, against a group median of -0.36.